findmyKOL

Mark Blitzer, MD

Basic profile

The Arrhythmia Institute

ORCIDNone on fileNPI
RegionNew Haven, CT · NortheastSpecialtyCardiovascular DiseaseFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2020Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Mark Blitzer is a Cardiology physician affiliated with The Arrhythmia Institute. OpenAlex indexes 19 publications with 535 citations (h-index 10).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
19publications

Distinct works indexed by OpenAlex.

535citations

Total citations across indexed works.

10h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
4companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

330 Orchard St.
Suite 210
New Haven, CT 065114429

Telephone

203-867-5400

Registry record last updated 2 Jul 2013.

View the NPPES registry record

Industry payments

4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    73.4%
    Beta blocker34.9%
    Metoprolol Succinate67%Sotalol14%Metoprolol Tartrate9%Carvedilol8%Atenolol2%
    Part D<11 patients
    Antiarrhythmic21.6%
    Flecainide Acetate48%Amiodarone Hcl38%Mexiletine Hcl8%Dofetilide6%
    Part D<11 patients

    + 7 more classes in this area

  • Blood & clotting

    25.8%
    Factor Xa inhibitor25.2%
    Eliquis74%Xarelto26%
    Part D112 patients
    P2Y12 inhibitor0.6%
    Clopidogrel100%
    Part D<11 patients
  • Hormonal (systemic)

    0.8%
    l-Thyroxine0.8%
    Levothyroxine Sodium100%
    Part D<11 patients
Where care is delivered (Part B)19.5% facility · 80.5% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”